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Background: Socioeconomic characteristics may affect the outcomes of patients treated with peritoneal dialysis
(PD). There are two major medical insurances in China: the New Cooperative Medical Scheme (NCMS), mainly for
rural residents, and the Urban Employees’ Medical Insurance (UEMI). The aim of the present study was to assess the
effect of medical insurance type on survival of patient undergoing PD.
Method: This was a prospective study in adult patients who underwent PD at the Wuhan No.1 Hospital between
January 2008 and December 2013. Patients had received continuous ambulatory PD for >3 months. Patients were
divided according to their medical insurance. Demographic and socioeconomic data, biochemical parameters and
primary clinical outcomes including all-cause mortality, switch to hemodialysis and kidney transplantation were analyzed.
Result: There were 415 patients with UEMI and 149 with NCMS. Compared with UEMI, patients with NCMS were
younger, and had shorter dialysis duration, smaller proportion of diabetic nephropathy, more severe anemia, and more
frequent hyperphosphatemia and hyperuricemia. Total Kt/V, creatinine clearance and residual renal function were not
different. There was no difference in technique survival (P > 0.05) between the two groups, but rural patients showed
lower overall survival (P < 0.05). Multivariate analysis showed that NCMS was independently associated with lower
survival (RR = 1.49; 95% CI = 1.04-2.15).
Conclusions: Medical insurance model is independently associated with PD patient survival.
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The association between patient characteristics and
clinical outcomes in patients treated with peritoneal
dialysis (PD) are complex and multifactorial [1-3].
Previous studies have shown that characteristics such
as lower income, lower education level and being female
were associated with higher mortality in PD patients [4-6].
In addition, dialysis patients living in rural areas have
higher mortality compared with urban residents [7]. On
the other hand, the patient volume of the PD center,
education level and the distance from the residence
to the hospital are associated with peritonitis, the
most important complication of PD [8,9]. In addition,
black race, diabetes and advanced age are predictors
of peritonitis occurrence [9,10]. Racial and insurance
disparity may affect the choice of treatment for patients* Correspondence: xiongfeimedsci@126.com
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unless otherwise stated.with end-stage renal disease (ESRD) [11]. However,
another study has shown that the economic status was
not independently associated with outcomes in a large
multicenter Brazilian cohort [12].
Approximately of 50% of Chinese people lives in rural
areas, and these areas are often underdeveloped and far
from hospitals. A previous study has shown that living
far from the PD unit was associated with shorter time to
first peritonitis episode, but was independently predictive
of higher rate of cure with antibiotics alone and trends to
lower rates of catheter removal and permanent switch to
hemodialysis (HD) [13]. Another study has shown that low
personal income influenced all-cause and cardiovascular
survival, and initial peritonitis in PD patients, whiles
education level predicted all-cause survival only for
patients living in underdeveloped regions [14].
In China, the two major medical insurance systems are
the New Cooperative Medical Scheme (NCMS) for rural
residents, and the Urban Employees’ Medical InsuranceThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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parities in the funding source, financing level and pro-
portion of reimbursement between the two insurance
systems [15]. Even if people participating in the NCMS
are less likely to become impoverished, NCMS reim-
bursement policies are far from optimal, which may
interfere with the choice of treatment and compliance
[16]. However, there is no study about the association
between disparities in medical insurance and PD out-
comes in China.
The present study examined the association between
insurance type and outcomes after initiation of PD in a
large volume PD center. Results of the present study
might provide a rationale for individualization and




This was a prospective observational cohort study in all
patients from the PD center of the Wuhan No.1 Hospital
(Wuhan, China) receiving PD between January 2008 and
December 2011. Patients were followed up until death or
December 31st, 2013 (the end of the study), after which
survival data were censored. Inclusion criteria were:
1) patients with ESRD; 2) aged 18-80 years; 3) received
continuous ambulatory PD for more than 3 months; and
4) provided complete information about their socioeco-
nomic status. Exclusion criteria were: 1) malignant disease;
2) refused to provide written consent; 3) unavailable or
incomplete data about clinical and laboratory examination;
or 4) the patient had no insurance. There is no automated
PD in our center.
This study was approved by the ethical committee of
the Wuhan No.1 Hospital and all participants provided a
written informed consent.
Data collection
Data were obtained from patient records and medical
staff reports. The demographic and socioeconomic data
included family income, educational level (illiteracy,
defined as less than elementary school, or literacy,
defined as elementary school graduate or higher), etiology
of chronic kidney disease (CKD), body mass index (BMI)
and blood pressure (BP). Biochemical parameters including
hemoglobin, serum albumin, serum creatinine, serum uric
acid, albumin-corrected calcium, serum phosphorus
and parathyroid hormone were measured at the central
laboratory of the Wuhan No.1 Hospital. All biochemical
parameters were measured at least yearly in all patients
after PD treatments, and the average for each parameter
was used in our analyses. Residual kidney function was
assessed using glomerular filtration rate (GFR). Total Kt/V
was calculated using the PD Adequest software 2.0(Baxter, Deerfield, IL, USA). GFR, in ml/min/1.73 m2, was
estimated from the mean values of creatinine clearance
(CrCL) and urea clearance, and adjusted for body surface
area [17].
Clinical outcomes
The primary clinical outcomes were all-cause mortality,
switch to HD and kidney transplantation. Causes of death
were grouped as: 1) cardiovascular death (myocardial
infarction, cardiac arrest, heart failure, cerebrovascular
accident, and other cardiac causes); 2) peritonitis-related
mortality; 3) treatment withdrawal for financial reasons
(gave up treatment if the family could not afford high
medical expenses); and 4) other or unknown causes.
Causes of switch to HD were grouped as: 1) peritonitis; 2)
inadequate dialysis (including ultrafiltration failure and
other medical causes); and 3) others (catheter-related
complications or medical problems such as pleural
effusions). For the purposes of this study, all out-
comes data (survival, transplantation, withdrawal, tech-
nique failure, etc.) for all patients were censored on
December 31st, 2013.
Statistical analyses
Continuous variables are expressed as mean ± SD for
normally distributed data, or as median and frequency
(%) for non-normally distributed data. Categorical data are
presented as proportions. Differences in demographics,
clinical characteristics and laboratory parameters between
the two groups were analyzed using the chi-square test for
categorical data, and the unpaired t-test for normally
distributed continuous data. Survival curves and survival
probabilities were generated using the Kaplan-Meier
method. Risk factors associated with mortality and
technique failure were determined by multivariate
Cox proportional hazards model. The covariates included
in the Cox regression models were age (as a continuous
variable), sex, education, insurance, BMI and laboratory
data (listed in Table 1). Statistical analysis was performed
using SPSS 17.0 (IBM, Armonk, NY, USA). Statistical
significance was defined as P < 0.05.
Results
Demographic and clinical characteristics
A total of 564 patients were included: 415 (77.0%) with
UEMI and 149 (23.0%) with NCMS. Baseline demographic
and clinical characteristics are presented in Table 2.
Compared with patients with UEMI, patients with
NCMS were younger (51.9 ± 14.7 vs. 57.3 ± 13.2 years,
P < 0.001), had a shorter dialysis duration (time from the
first PD treatment to study recruitment; 22.8 ± 17.6 vs.
31.4 ± 25.8 months, P = 0.01), had a smaller proportion of
diabetic nephropathy (DN) (6.0% vs. 16.1%, P = 0.02)
and had a higher proportion of illiteracy (71.1% vs.
Table 1 Biochemical characteristics of the study patients (data are averages over the duration of the study)
Characteristics Urban medical insurance (n = 415) Rural medical insurance (n = 149) P-value
HGB (g/L) 95.19 ± 21.13 89.83 ± 23.98 0.011
FERR (μg/L) 201.97 ± 209.17 232.33 ± 236.90 0.178
Ca (mmol/L) 2.15 ± 0.25 2.06 ± 0.25 <0.001
P (mmol/L) 1.69 ± 0.52 1.81 ± 0.53 0.019
PTH (pg/ml) 459.93 ± 475.38 468.95 ± 433.90 0.845
ALB (g/L) 36.33 ± 4.61 36.39 ± 5.06 0.900
BUN (mmol/L) 18.37 ± 13.16 19.21 ± 7.98 0.464
Cr (μmol/L) 878.31 ± 288.66 923.03 ± 314.03 0.114
UA (mmol/L) 413.09 ± 84.63 431.68 ± 87.35 0.023
nPCR (g/kg/d) 0.95 ± 0.23 0.95 ± 0.21 0.778
D/P at 4 hours 0.66 ± 0.14 0.68 ± 0.15 0.156
Kt/V 1.75 ± 0.55 1.68 ± 0.59 0.164
CrCL (L/W)* 61.28 ± 35.65 59.20 ± 22.91 0.506
GFR# 1.88 ± 2.64 2.14 ± 2.46 0.297
PD volume (ml) 7228.16 ± 1546.17 6572.41 ± 1484.85 <0.001
Data are presented as mean ± SD or median (range).
HGB: hemoglobin; FERR: Ca: calcium; P: phosphorus; PTH: parathyroid hormone; ALB: albumin; BUN: blood urea nitrogen; Cr: creatinine; UA: uric acid;
nPCR: normalized protein catabolic rate; D/P: dialysate/plasma creatinine; Kt/V: dialysis efficiency; CrCL: creatinine clearance rate; GFR: glomerular filtration rate;
PD: peritoneal dialysis.
*Adjusted for BSA.
#GFR, in ml/min/1.73 m2, was estimated from the mean values of creatinine clearance and urea clearance, and adjusted for body surface area [17].
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and systolic BP between the two groups.
Biochemical parameters
During follow-up, patients with NCMS showed lower iron
levels (89.83 ± 23.98 vs. 95.19 ± 21.13 g/L, P = 0.01),
higher phosphorus levels (1.81 ± 0.53 vs. 1.69 ± 0.52 mmol/
L, P = 0.02), and lower calcium levels (2.06 ± 0.25 vs. 2.15 ±
0.25 mmol/L, P < 0.001) compared with patients with
UEMI. There was no difference in albumin, creatinine, urea
nitrogen and normalized protein catabolic rate (nPCR)
between the two groups (Table 1).Table 2 Demographic and baseline characteristics of the pati
Characteristics Urban medical insurance
Age (yr) 57.34 ± 13.21
Male, n (%) 209 (50.4%)
Education level, n (%) Illiteracy Literacy 183 (44.1%) 232 (55.9%)
DN, n (%) 67 (16.1%)
Dialysis duration* (months) 31.40 ± 25.80
Body weight (kg) 60.28 ± 11.01
BMI (kg/m2) 22.46 ± 3.38
SBP (mmHg) 137.56 ± 16.92
DBP (mmHg) 82.46 ± 10.54
DN: diabetic nephropathy; BMI: body mass index; SBP: systolic blood pressure; DBP:
*Time from the first PD treatment to study recruitment.PD prescription and adequacy data
During follow-up, despite rural patients having a smaller
PD volume (6572 ± 1484 vs. 7228 ± 1546 ml, P < 0.001),
comparison of adequacy data showed that total Kt/V
and CrCL were not different, and that residual GFR was
not different between the two groups (Table 2).
Clinical outcome
Among all patients, 173 (41.7%) patients with UEMI and
58 (38.9%) patients with NCMS ceased treatment before
the end of the study. There was no difference in unadjusted
death rates between groups on a univariate analysis. Deathents
(n = 415) Rural medical insurance (n = 149) P-value
51.85 ± 14.65 <0.001
89 (49.6%) 0.677
106 (71.1%) 43 (28.9%) <0.001
9 (6.0%) 0.02
22.84 ± 17.59 0.01
60.35 ± 10.18 0.947
22.26 ± 3.04 0.531
139.24 ± 18.10 0.411
86.47 ± 12.23 0.002
diastolic blood pressure.
Table 4 Causes of switch to HD
Characteristics Urban medical
insurance (n = 66)
Rural medical
insurance (n = 12)
P-value
Peritonitis, n (%) 48 (72.7%) 7 (58.3%) 0.314
Inadequate dialysis,
n (%)
5 (7.6%) 1 (8.3%) 0.928
Others, n (%) 13 (19.7%) 4 (33.3%) 0.293
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no significant difference between the two groups (21.9% vs.
26.2%, P = 0.29). However, switch to HD was less frequent
in patients with NCMS (15.9% vs. 8.1%, P = 0.02). Patients
with NCMS had a shorter time on therapy compared with
patients with UEMI (27.4 ± 19.9 vs. 36.6 ± 25.7 months,
P = 0.01; unadjusted data) (Table 3).
Predictors of technique failure
During follow-up, 78 patients switched to HD. Peritonitis
was the main cause of technique failure in both groups,
followed by inadequate dialysis. The distribution of different
causes of technique failure was similar between the two
groups (Table 4; unadjusted data).
The technique survival rates at 1, 2, 3 and 5 years were
96.5%, 91.4%, 85.9% and 73.3%, respectively, for patients
with NCMS, and 95.8%, 92.0%, 87.0% and 81.5%,
respectively, for patients with UEMI (P = 0.245) (Figure 1).
After adjustment for demographic and clinical characteris-
tics, Cox model analysis showed that diabetic nephropathy
(relative risk (RR) = 1.85, 95% confidence interval (95% CI):
1.10-3.13) and lower albumin (RR = 0.90, 95% CI:
0.86-0.94) were independent predictors of technique
failure in all patients.
Patient survival and predictors of mortality
In the present study, patient survival according to insurance
type was the primary outcome. Cardiovascular diseases
were the main cause of death in both groups (25.6% vs.
35.2%, P = 0.29). Treatment withdrawal for financial rea-
sons was more frequent in patients with NCMS compared
with patients with UEMI (15.4% vs. 1.1%, P = 0.001)
(Table 5). The unadjusted patient survival rate at 1, 2, 3 and
5 years were 94.0%, 81.1%, 73.0% and 58.4%, respectively, in
patients with NCMS, and was 97.5%, 89.2%, 81.2% and
68.9%, respectively, in patients with UEMI. Kaplan-Meier
analysis showed a higher survival in patients with UEMI
(P < 0.05) (Figure 2). The relative risk of death for rural
patients was 1.49 (95% CI, 1.04-2.15). Multivariate Cox
regression analysis showed that education level, insurance
type, age, albumin, serum phosphorus, peritoneal equilibra-
tion test and total Kt/V were independent predictors
of patient survival in the combined cohort (Table 6).Table 3 Causes for ceasing peritoneal dialysis
Characteristics Urban medical
insurance (n = 415)
Rural medical
insurance (n = 149)
P-value
Death, n (%) 91 (21.9%) 39 (26.2%) 0.291
Switch to HD,
n (%)
66 (15.9%) 12 (8.1%) 0.017
Transplant, n (%) 15 (3.6%) 5 (3.4%) 0.884
Others, n (%) 1 (0.2%) 2 (1.3%) 0.113
TOT (month) 36.55 ± 25.74 27.36 ± 19.88 0.014
HD: hemodialysis; TOT: time on treatment.Discussion
The present study was a prospective analysis of the rela-
tionship between clinical outcomes of PD and medical
insurance model. Data showed that patients with NCMS
had more severe anemia and hyperphosphatemia, and
that survival was significantly lower in patients with
NCMS compared with patients with UEMI. However,
the technique failure rate was similar between the two
groups.
Insurance disparity may affect the choice of treatment
for patients with ESRD, as shown in the United States
[11], South America [18] and Australia [19]. However,
another study has shown that the economic status was
not independently associated with outcomes in a large
multicenter Brazilian cohort [12]. The primary outcome
of the present study was to assess the association between
insurance type and survival in PD patients, and results
showed that PD patients with NCMS had a lower survival
compared with PD patients with UEMI. Many factors
might be responsible for this observation, such as educa-
tion, nutrition, distance between home and hospital.
Results of the present study are supported by a study from
Columbia that showed that PD and hemodialysis patients
with poor medical insurance coverage had lower survivalFigure 1 Patient PD technique survival for urban and rural
patients.
Table 5 Causes of mortality
Causes of death Urban medical
insurance (n = 91)
Rural medical
insurance (n = 39)
P-value
CVD, n (%) 32 (35.2%) 10 (25.6%) 0.287
Peritonitis, n (%) 17 (18.7%) 3 (7.7%) 0.112
Financial reasons,
n (%)
1 (1.1%) 6 (15.4%) 0.001
Other, n (%) 41 (45.1%) 20 (51.3%) 0.514
CVD: cardiovascular death.
Table 6 Predictors of mortality on Cox multivariate
analysis
Characteristics P value RR 95% CI
Education level <0.01 0.52 0.35, 0.76
Insurance model 0.03 1.49 1.04, 2.15
Albumin 0.01 0.95 0.91, 0.98
Age <0.01 1.03 1.02, 1.04
Kt/V 0.01 0.64 0.46, 0.89
Peritoneal equilibrium test <0.01 0.21 0.11, 0.40
Phosphorus 0.04 1.41 1.02, 1.95
Kt/V: dialysis efficiency; RR: relative risk; 95% CI: 95% confidence interval.
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mortality due to financial reasons was higher in patients
with NCMS compared with UEMI, underlining the
importance of economics and insurance coverage in
ESRD survival.
Previous studies in China showed that a high school
education or higher was less frequent in rural areas and
that the prevalence of CKD was higher compared with
urban patients [21]. The present study showed that in
accordance with their economic status, rural patient had
a low education level. In addition, rural patients were
younger, which might be related to a lower awareness of
CKD, which may delay treatments in these patients and
ultimately allow CKD to progress to ESRD.
Previous studies showed that Chinese rural patients
have a lower proportion of hypertension and diabetes
control [22,23]. In the present study, fewer rural patients
suffered from diabetic nephropathy, and their diastolic
BP control was inferior compared with urban patients,
which is similar to previous epidemiological data from
China [22,23].
Low hemoglobin levels, hyperphosphoremia, malnutrition
and lower residual renal function are predictors of mortality
in PD patients, and these predictors are independent fromFigure 2 Patient survival for urban and rural PD patients.gender, race and dialysis buffer [6,24-26]. In our center, we
observed that patient with NCMS had lower hemoglobin
levels compared with patients with UEMI, which might be
a consequence of malnutrition due to a lower economic
status. In addition, these patients are less likely to be able to
afford intravenous iron and erythropoiesis-stimulating agent
therapy. Foods with high protein content are also an
important source of dietary phosphorus [27]. However,
even if patients with NCMS are able to consume
high-protein foods, they usually are unable to afford
phosphorus binders such as sevelamer carbonate and
lanthanum carbonate. As a result, hyperphosphatemia
was more common in rural patients even if albumin
levels and nPCR were not significantly different between
the two groups. Finally, we observed no difference on
residual renal function between the two groups, and we
presume that it may be related to the longer dialysis
duration for patients with UEMI.
Studies have shown that mortality was higher among
PD patients who lived farther from their attending
nephrologist compared with patients who lived closer,
which may be the result of less frequent contact with
a nephrologist for patients in remote areas [28-30].
However, another study has shown that although the
risk of death was significantly higher in remote dwellers,
distance from the dialysis center and residing in rural
areas did not affect the risk of technique failure or death
[31]. In China, patients with NCMS mainly live in rural
areas, which are often underdeveloped areas far from any
hospital compared with patients with UEMI. They live
farther from their treating center and have less
contact with their physician. Dialysis inadequacy is an
important predictor for mortality in PD patient, espe-
cially for anuric patients [32]. Studies have shown
that a Kt/V <1.7 was associated with an increased risk
of mortality and hospitalization, and that this obser-
vation persisted after multivariate adjustment [33].
The present study suggests that although the dialysis
volume was lower in rural patients compared with
urban patients, the Kt/V and CrCL were not different
between the two groups, indicating that the different
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clearance.
Previous studies have shown that the main causes of
switching from PD to HD were infections, fluid overload,
abdominal surgery, malnutrition, decreased mental capacity
and abdominal wall defect [34]. Despite a probable higher
rate of malnutrition among rural patients compared urban
patients, we did not observe any difference in the rate of
switching to HD. This may be because the switching rate is
affected by many factors, and because we did not assess all
of them in the present study. Further studies are needed to
assess this specific issue. Nevertheless, a likely explanation
might be the lack of access to a HD facility in remote rural
areas. As for the similarity in transplantation rate, the lim-
ited access to compatible donor kidneys might be a limiting
factor that is more important than financial reasons.
Peritonitis is the most frequent cause of peritoneal dialysis
failure, and significantly affects patient mortality [35].
However, it is a modifiable factor and the patients may be
switched to hemodialysis [36]. In addition, a previous study
has shown that living more than 100 km from a dialysis unit
increased the risk of S. aureus peritonitis [13]. In the present
study, data from patients with technique failure showed that
peritonitis was the major cause of switching to hemodialysis,
and that there was no difference between the two groups.
Therefore, the higher rate of treatment cessation in patients
with NCMS may be related to the lower survival. In
addition, results showed that DN and hypoalbuminemia
were independent predictors for technique failure.
This study has several limitations. First, data were
from a single center and the sample was small, pre-
venting extrapolation of the results to all Chinese
patients with ESRD and to other countries. We did
not evaluate the comorbidities and previous treatments at
enrollment. We did not evaluate the distances between
the patient, his family and the hospital. Finally, the
cause of death for many patients had to be presumed
by the nephrologist, especially for the patients who
died at home.
Conclusions
In summary, biomedical parameters were inferior in
patients with NCMS compared with patients with
UEMI. Although the technique failure rate was similar
between the two groups, survival was lower in patients
with NCMS. Therefore, in light of our findings, we suggest
that the medical coverage rate for patients with ESRD
needs to be improved. Health policy makers should
consider building satellite PD centers and developing
PD networks to standardize the training programs. For
the nephrologists, there is a need to reinforce tar-
geted intervention for rural patients and to imple-
ment suitable treatments based on their economic
status and insurance type.Abbreviations
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